Myofibroblast-mediated mechanisms of pathological remodelling of the heart
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2012/12/04
-
Journal
-
Indian UGC (journal)
-
Refrences160
-
Citations445
-
Karl T. Weber
-
Yao Sun
-
Syamal K. Bhattacharya
-
Robert A. Ahokas
-
Ivan C. Gerling
Cite
Weber, Karl T., et al. “Myofibroblast-Mediated Mechanisms of Pathological Remodelling of the Heart”. Nature Reviews Cardiology, vol. 10, no. 1, 2012, pp. 15-26, https://doi.org/10.1038/nrcardio.2012.158.
Weber, K. T., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., & Gerling, I. C. (2012). Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nature Reviews Cardiology, 10(1), 15-26. https://doi.org/10.1038/nrcardio.2012.158
Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nature Reviews Cardiology. 2012;10(1):15-26.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the circulatory (Cardiovascular) system
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the respiratory system
Medicine
Medicine (General)
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| 10.1007/978-94-007-2869-1_11 | 2012 | |||
| Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states | Pflügers Archiv - European Journal of Physiology |
| 27 | 2012 |
| Recent Developments in Myofibroblast Biology | The American Journal of Pathology |
| 910 | 2012 |
| Matrix control of transforming growth factor- function | The Journal of Biochemistry |
| 181 | 2012 |
| 10.1161/CIRCULATIONAHA.112.125013 | Circulation |
| 2012 |
Refrences Analysis
The category
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system 231
is the most frequently represented among the references in this article. It primarily includes studies from Journal of the American College of Cardiology and Circulation Research. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Morroniside improves AngII-induced cardiac fibroblast proliferation, migration, and extracellular matrix deposition by blocking p38/JNK signaling pathway through the downregulation of KLF5 | Naunyn-Schmiedeberg's Archives of Pharmacology |
| 2024 | |
| PCSK9 regulates myofibroblast transformation through the JAK2/STAT3 pathway to regulate fibrosis after myocardial infarction | Biochemical Pharmacology |
| 2024 | |
| Beyond conduction impairment: Unveiling the profound myocardial injury in left bundle branch block | Heart Rhythm |
| 2024 | |
| Prenatal hormone stress triggers embryonic cardiac hypertrophy outcome by ubiquitin-dependent degradation of mitochondrial mitofusin 2 | iScience | 2024 | ||
| Fabrication of Micropatterns of Aligned Collagen Fibrils | Langmuir |
| 2024 |
Citations Analysis
The category
Medicine: Medicine (General) 186
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Investigational drugs targeting cardiac fibrosis and was published in 2013. The most recent citation comes from a 2024 study titled Notum protects against myocardial infarction-induced heart dysfunction by alleviating cardiac fibrosis. This article reached its peak citation in 2016, with 52 citations. It has been cited in 228 different journals, 23% of which are open access. Among related journals, the Journal of Molecular and Cellular Cardiology cited this research the most, with 34 citations. The chart below illustrates the annual citation trends for this article.